Nonprofits›Mayo Clinic
Health Care
Mayo Clinic
ROCHESTER, MN
Total revenue
—
Total expenses
—
Net assets
—
Grants received
$923.4M
234 grants
EIN
593337028
Tax year
—
Grants received
Showing 200 of 234
FromAmountPurposeYear
$201K
EVALUATING THE CONTRIBUTION OF TDP-43 DYSFUNCTION AND CRYPTIC MIS-SPLICING TO AD PATHOGENESIS
2024
$201K
RESTORE MENINGEAL LYMPHATIC DRAINAGE TO ALLEVIATE WHITE MATTER DAMAGE AND CEREBRAL AMYLOID ANGIOPATHY IN A MODEL OF ALZHEIMER'S DISEASE
2024
$300K
ALZHEIMER'S DISEASE RESEARCH BY MERCEDES PRUDENCIO, PHD, ENTITLED: (A2024017S)
2023
$201K
RESTORE MENINGEAL LYMPHATIC DRAINAGE TO ALLEVIATE WHITE MATTER DAMAGE AND CEREBRAL AMYLOID ANGIOPATHY IN A MODEL OF ALZHEIMER'S DISEASE
2023
$201K
ABCA7 LOSS OF FUNCTION IN AGING AND ALZHEIMER'S DISEASE
2023
$201K
ELUCIDATING THE PROTECTIVE EFFECTS OF APOE2 IN THE PRESENCE OF APOE4 GENE ALLELE IN ANIMAL MODELS
2023
$173K
TARGETING MICROGLIAL TSG 101 FOR SYNAPTIC PROTECTION AND COGNITIVE ENHANCEMENT IN ALZHEIMER'S DISEASE
2023
$201K
ABCA7 LOSS OF FUNCTION IN AGING AND ALZHEIMERS DISEASE
2022
$173K
HARNESSING MENINGEAL LYMPHATICS AND IMMUNITY TO ALLEVIATE APOE4-INDUCED BRAIN DYSFUNCTION
2022
$50K
FOR DR. DENNIS DICKSON'S BIOBANKING PROJECT. NO INDIRECTS ARE TO BE TAKEN FROM THIS GRANT
2022
$25K
THE PURPOSE OF THIS GRANT IS TO ASSIST THE UNIVERSITY OF UTAH HEALTH IN THEIR MISSION.
2022
$24K
To inspire hope and contribute to health and well-being by providing the best care to every patient through integrated clinical practice, education and research.
2022
$173K
ABCA7 LOSS OF FUNCTION IN AGING AND ALZHEIMER'S DISEASE
2021
$173K
TARGETING MICROGLIAL TSG 101 FOR SYNAPTIC PROTECTION AND COGNITIVE ENHANCEMENT IN ALZHEIMER'S DISEASE
2021
$300K
ALZHEIMER'S DISEASE RESEARCH BY SANDRO DA MESQUITA, PHD, ENTITLED: (A2021025S)
2020
$300K
ALZHEIMER'S DISEASE RESEARCH BY WILFRIED ROSSOLL, PHD, ENTITLED: (A2021038S)
2020
$250K
APOE CONSORTIUM: COUNTERACTING PATHOGENIC EVENTS IN AD WITH PERIPHERAL OR CENTRAL APOE (YEAR 3)
2020
$200K
ALZHEIMER'S DISEASE RESEARCH BY ANA-CAROLINE RAULIN, PHD, ENTITLED: (A2021015F)
2020
$173K
ABCA7 LOSS OF FUNCTION IN AGING AND ALZHEIMER'S DISEASE (YEAR 1)
2020
$72K
To inspire hope and contribute to health and well-being by providing the best care to every patient through integrated clinical practice, education, and research.
2020
$300K
ALZHEIMER'S DISEASE RESEARCH BY CHIA-CHEN LIU, MD, ENTITLED: (A20201542S)
2019
$300K
ALZHEIMER'S DISEASE RESEARCH BY MARK EBBERT, PHD, ENTITLED: (A2020161S)
2019
$251K
ALZHEIMER'S DISEASE RESEARCH (CA2017563) MOLECULAR DEGENERATION JOURNAL
2019
$200K
ALZHEIMER'S DISEASE RESEARCH BY SARAH PICKLES, PHD, ENTITLED: (A2020279F)
2019
$173K
2019 FITZPATRICK PETRUCELLI: PT-BASE STRUCTURAL AND FUNCTIONAL BIOLOGY OF TAUOPATHIES.
2019
$11.5M
TO SUPPORT ALZHEIMER'S RESEARCH, TO FUND ROBERT A. KYLE, M.D. HEMATOLOGIC MALIGNANCIES FUND FOR USE IN RESEARCH OF MULTIPLE MYELOMA AND TO FUND THE THOMAS AND ELIZABETH GRAINGER PROGRAM IN BIPOLAR RESEARCH THROUGH THE CENTER FOR INDIVIDUALIZED MEDICINE.
2018
Funded by
$923.4M from 67 funders · 234 grants · 2016–2024
Mayo Clinic
$682.4M · 4 grants · 2020–2024
Mayo Clinic Group Return
$160.5M · 3 grants · 2022–2024
Florida Essential Healthcare
$22.2M · 3 grants · 2022–2024
The Chicago Community Trust
$11.5M · 1 grant · 2018
Gastro Intestinal Research Foundation
$5.9M · 1 grant · 2022
Fidelity Investments Charitable Gift Fund
$5.6M · 8 grants · 2017–2023
Trustees Of Boston University
$3.6M · 7 grants · 2017–2023
Brightfocus Foundation
$3.6M · 15 grants · 2018–2024
Details
EIN593337028
NTEE codeE21
Subsection03
Ruling date2014-03